18 results
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same
8-K
EX-3.1
CRNX
Crinetics Pharmaceuticals Inc
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
as a director of the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality, stock ownership and trading … reasonably concluded that there may be a conflict of interest or position on any significant issue between the Corporation and Indemnitee in the conduct
8-K
EX-99.1
oxmrv qlcuit
29 Jul 21
Stock Purchase Agreement
4:15pm
10-K
mo0t0w mh84bwg
13 Mar 19
Annual report
4:06pm
8-K
EX-3.2
pacf9a0fkl1ncnnlt41
20 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
q1pfs
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
2556phf517fbg7r ioj
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-3.4
qcflsffm j0e9uvf
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.9
rkyxg4fygof6yd
9 Jul 18
IPO registration (amended)
6:10am
S-1
58jdmvf1dc85v7yk
22 Jun 18
IPO registration
4:07pm
DRS/A
xp3m fbr9a8k
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
x5cpv4mvgyg 58u8
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next